ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 100 filers reported holding ENDOCYTE INC in Q4 2014. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $44,000 | -18.5% | 29,221 | +39.5% | 0.00% | – |
| Q1 2017 | $54,000 | -54.6% | 20,951 | -55.3% | 0.00% | – |
| Q4 2016 | $119,000 | +50.6% | 46,828 | +84.2% | 0.00% | – |
| Q3 2016 | $79,000 | -26.2% | 25,428 | -23.9% | 0.00% | – |
| Q2 2016 | $107,000 | +35.4% | 33,417 | +31.4% | 0.00% | – |
| Q1 2016 | $79,000 | -22.5% | 25,428 | 0.0% | 0.00% | – |
| Q4 2015 | $102,000 | -60.5% | 25,428 | -54.9% | 0.00% | -100.0% |
| Q3 2015 | $258,000 | -11.9% | 56,428 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $293,000 | -19.7% | 56,428 | -3.2% | 0.00% | 0.0% |
| Q1 2015 | $365,000 | +29.0% | 58,312 | +29.8% | 0.00% | 0.0% |
| Q4 2014 | $283,000 | +3.7% | 44,925 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $273,000 | -6.8% | 44,925 | +0.9% | 0.00% | 0.0% |
| Q2 2014 | $293,000 | -62.0% | 44,536 | +37.3% | 0.00% | -75.0% |
| Q1 2014 | $772,000 | +120.6% | 32,442 | -0.8% | 0.00% | +300.0% |
| Q4 2013 | $350,000 | -21.2% | 32,703 | -1.7% | 0.00% | -50.0% |
| Q3 2013 | $444,000 | +49.0% | 33,278 | +46.5% | 0.00% | 0.0% |
| Q2 2013 | $298,000 | – | 22,723 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |